SCHULTES BIRGIT C (EVP, Chief Scientific Officer) sold 0.0% of their position (31.00 shares) of INTELLIA THERAPEUTICS, INC. on the open market
Open‑market sale worth $538.78 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/3/2025ACC: 0001193125-25-230424
Officer· EVP, Chief Scientific Officer
Since Mar 2026
-31.00
Net shares
Net seller
$538.78
Total sold
1
Open market trades
0B · 1S
1
Total transactions
31.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−31.00
Price / share
$17.38
Trade value
$538.78
% of position
0.0%
10/1/2025
105.22K→105.18K
Total
Net shares
−31.00
Net value
-$538.78
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/1/2025 | S · Sale | −31.00 | $17.38 | $538.78 | 0.0% | 105.22K | 105.18K |
| Total | −31.00 | -$538.78 | ||||||
Derivative Transactions0
No derivative transactions reported